Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.030
-0.020 (-0.66%)
Nov 16, 2026, 4:00 PM EST - Market closed

Protalix BioTherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2551451381306938
Market Cap Growth
49.76%4.57%6.60%87.08%83.20%-68.02%
Enterprise Value
2161241171158226
Last Close Price
3.031.801.881.781.370.83

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.30-47.2115.62--
Forward PE
25.2510.293.9413.1760.89111.67
PS Ratio
3.022.752.591.981.460.99
PB Ratio
3.103.003.203.87-6.52-6.28
P/TBV Ratio
3.173.003.203.87--
P/FCF Ratio
16.96-18.73---
P/OCF Ratio
14.55-15.96---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.552.342.191.751.720.68
EV/EBITDA Ratio
8.06-22.359.86--
EV/EBIT Ratio
8.57-29.8010.98--
EV/FCF Ratio
14.34-15.79---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.170.130.78-3.15-5.54
Debt / EBITDA Ratio
0.32-0.812.00--
Debt / FCF Ratio
0.61-0.75---
Net Debt / Equity Ratio
-0.49-0.45-0.68-0.55-1.060.91
Net Debt / EBITDA Ratio
-1.475.44-5.61-1.57-0.950.28
Net Debt / FCF Ratio
-2.611.61-3.967.41-0.440.47
Asset Turnover
0.850.680.680.930.740.54
Inventory Turnover
1.561.951.822.192.791.05
Quick Ratio
2.071.501.491.110.841.29
Current Ratio
3.272.512.351.541.381.86
Return on Equity (ROE)
30.80%-14.44%7.64%72.50%--
Return on Assets (ROA)
15.72%-4.41%3.10%9.32%-12.57%-18.06%
Return on Invested Capital (ROIC)
49.42%-27.37%18.94%52.52%-40.77%-186.45%
Return on Capital Employed (ROCE)
28.60%-9.90%8.20%26.90%-55.70%-50.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
8.13%-4.56%2.12%6.40%-21.50%-72.80%
FCF Yield
5.90%-9.42%5.34%-1.90%-36.92%-31.00%
Buyback Yield / Dilution
3.09%3.10%1.66%-70.04%-9.81%-51.43%
SEC Filings: 10-K · 10-Q